Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;100(2):459.
doi: 10.1016/j.kint.2021.06.005. Epub 2021 Jun 10.

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine

Clare Morlidge  1 , Sally El-Kateb  2 , Praveen Jeevaratnam  2 , Barbara Thompson  2
Affiliations

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine

Clare Morlidge et al. Kidney Int. 2021 Aug.
No abstract available

PubMed Disclaimer

References

    1. Clajus C., Spiegel J., Brocker V. Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphtheria-poliomyelitis-vaccination. BMC Nephrol. 2009;10:21. - PMC - PubMed
    1. Kielstein J.T., Termuhlen L., Sohn J. Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol. 2000;54:246–248. - PubMed
    1. Kikuchi Y., Imakiire T., Hyodo T. Minimal change nephrotic syndrome, lymphadenopathy and hyperimmunoglobulinemia after immunization with a pneumococcal vaccine. Clin Nephrol. 2002;58:68–72. - PubMed
    1. Abeyagunawardena A., Goldblatt D., Andrews N., Trompeter R. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet. 2003;362:449–450. - PubMed
    1. Lebedev L., Sapojnikov M., Wechsler A. Minimal change disease following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78:142–145. - PMC - PubMed